Effect of melatonin on NF-κB DNA-binding activity in the rat spleen

Cell Biology International

Volumn 20, Issue 10, 1996, Pages 687-692

  Chuang, Jih Ing ^a,b   Mohan, Natarajan ^a   Meltz, Martin L ^a   Reiter, Russel J ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Antioxidant; Free radical; Melatonin; NF B; Spleen

Indexed keywords

DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MELATONIN;

ANIMAL TISSUE; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; HORMONAL REGULATION; MALE; NONHUMAN; PROTEIN DNA BINDING; RAT; SPLEEN;

ANIMALIA;

EID: 0030272628     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1006/cbir.1996.0091     Document Type: Article

References (38)

1. BAEUERLE PA, BALTIMORE D, 1988. I-κB: a specific inhibitor of the NF-κB transcription factor. Science 242: 540-546.
2. BAEUERLE PA, 1991. The inducible transcription activator NF-κB: regulation by distinct protein subunits. Biochem Biophysic Acta 1072: 63-80.
3. BARLOW-WALDEN LR, REITER RJ, ABE M, PABLOS MI, MENENDEZ-PELAEZ A, CHEN LD, POEGGELER B, 1995. Melatonin stimulates brain glutathione peroxidase activity. Neurochem Int 26: 497-502.
4. CAROLEO MC, DORIA G, NISTICO G, 1994. Melatonin restores immunodepression in aged and cyclophosphamide-treated mice. Ann NY Acad Sci 719: 343-352.
5. CAULEY K, VERMA IM, 1994. KB enhancer-binding complexes that do not contain NF-κB are developmentally regulated in mammalian brain. Proc Natl Acad Sci USA 91: 390-394.
6. DROGE W, SCHULZE-OSTHOFF K, MIHM S, et al., 1994. Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J 8: 1131-1138.
7. GREENE WC, 1990. Regulation of HIV-1 gene expression. Ann Rev Immunol 8: 453-475.
8. LENARDO MJ, FAN CM, MANIATIS T, BALTIMORE D, 1989. Pleiotropic mediator of inducible and tissue-specific gene control. Cell 57: 287-294.
9. LIBERMANN TA, BALTIMORE D, 1990. Activation of interleukin-6 gene expression through the NF-κB transcription factor. Mol Cell Biol 10: 2327-2334.
10. 2· in the production of HO·: In vitro and in vivo. Free Radic Biol Med 16: 29-33.
11. LISSONI P, BARNI S, TANCINI G, ROVELLI F, ARDIZZOIA A, CONTI A, MAESTRONI GJM, 1993. A study of the mechanisms involved in the immunostimulatory action of the pineal hormone in cancer patients. Oncology 50: 399-402.
12. MAESTRONI GJM, CONTI A, COVACCI V, 1994. Melatonin-induced immuno-opioids: fundamentals and clinical perspectives. In Maestroni GJM, Conti A, Reiter RJ, eds. Adv Pineal Res 7: 73-81.
13. MAESTRONI GJM, CONTI A, PIERPAOLI W, 1988. Pineal melatonin and its fundamental immunoregulatory role in aging and cancer. Ann NY Acad Sci 521: 140-148.
14. MAESTRONI GJM, CONTI A, PIERPAOLI W, 1986. Role of the pineal gland in immunity: circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone. J Neuroimmunol 13: 19-30.
15. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO 12: 2005-2015.
16. MIHM S, ENNEN J, PESSARA U, KURTH R, DROGE W, 1993. Inhibition of HIV-1 replication and NF-κB activity by cysteine and cysteine derivatives. AIDS 5: 497-503.
17. MOHAN N, MELTZ ML, 1994. Induction of nuclear factor KB after low-dose ionizing radiation involves a reactive oxygen intermediate signaling pathway. Radiat Res 140: 97-104.
18. MORREY KM, MCLACHLAN JA, SERKIN CD, MARCHESELLI F, 1994. Activation of human monocytes by the pineal hormone melatonin. J Immunol 153: 2671-2680.
19. PIERI C, MARRA M, MORONI F, RECCHIONI R, MARCHESELLI F, 1994. Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci 15: PL271-276.
20. RADOSEVIC-STASIC B, JONJC S, RUKAVINS D, 1983. Immune response of rats after pharmacologic pinealectomy. Period Biol 85: 119-121.
21. 125I]iodomelatonin by rat splenocytes: characterization and its role in regulation of cyclic AMP production. J Neuroimmunol 57: 171-178.
22. REGELSON W, PIERPAOLI W, 1987. Melatonin: a rediscovered antitumor hormone? Its relation to surface receptors, sex, steroid metabolism, immunologic response and chronobiological factors in tumor growth and therapy. Cancer Inv 5: 379-385.
23. REITER RJ, 1991. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocrin Rev 12: 151-180.
24. REITER RJ, 1993. The melatonin rhythm: both a clock and a calendar. Experientia 49: 654-664.
25. REITER RJ, 1994. Free radical, melatonin, and cellular antioxidative defence mechanisms. In Gupta G, Wallmann HA, Fedor-Fregbergh PG, eds. Pathophysiology of Immune Neuroendocrine Communication Circuit. Verlag. Stuttgart, 135-160.
26. REITER RJ, MELCHIORRI D, SEWERYNEK E, et al., 1995. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 18: 1-11.
27. ROEDERER M, STAAL FJT, RAJU PA, ELA SW, HERZENBERG LA, HERZENBERG LA, 1990. Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Proc Natl Acad Sci USA 87: 4884-4888.
28. SATRIANO J, SCHLONDORFF D, 1994. Activation and attenuation of transcription factor NF-κB in mouse glomerular mesangial cells in response to tumor necrosis factor-α, immunoglobulin G, and adenosine 3′:5′-cyclic monophosphate. J Clin Invest 94: 1629-1636.
29. SCHENK H, KLEIN M, ERDBRUGGER W, DROGE W, SCHULZE-OSTHOFF K, 1994. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-κB and AP-1. Proc Natl Acad Sci USA 91: 1672-1676.
30. SCHRECK R, BAEUERLE PA, 1991. A role for oxygen radicals as second messengers. Trends Cell Biol 1: 39-42.
31. SCHRECK R, REIBER P, BAEUERLE A, 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO 10: 2248-2258.
32. SCHRECK R, MEIER B, MANNEL DN, DROGE W, BAEUERLE PA, 1992. Dithiocarbamates as potent inhibitors of nuclear factor KB activation in intact cells. J Exp Med 175: 1181-1194.
33. SEWERYNEK E, ABE M, REITER RJ, et al., 1995. Melatonin administration prevents lipopolysaccharide-induced oxidative damage in phenobarbital-treated animals. J Cell Biochem 58: 436-444.
34. SHIRAKAWA F, CHEDID M, SUTTLES J, POLLOK BA, MIZEL SB, 1989. Interleukin-1 and cyclic AMP induce κ immunoglobulin light-chain expression via activation of an NF-κB-like DNA-binding protein. Mol Cell Biol 9: 959-964.
35. STAAL FJT, ROEDERER M, RAJU PA, ANDERSON MT, ELA SW, HERZENBERG LA, HERZENBERG LA, 1993. Antioxidants inhibit stimulation of HIV transcription. AIDS Res Hum Retroviruses 9: 299-306.
36. SZE SF, LIU WK, NG TB, 1993. Stimulation of murine splenocytes by melatonin and methoxytryptamine. J Neural Transm (Gen Sect) 94: 115-126.
37. TAN DX, CHEN LD, POEGGELER B, MANCHESTER LC, REITER RJ, 1993. Melatonin: A potent endogenous hydroxyl radical scavenger. Endocrine J 1: 57-60.
38. TOLEDANO MB, LEONARD WJ, 1991. Modulation of transcription factor NF-κB binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci USA 88: 4328-4332.